{
  "ticker": "AMGN",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T08:23:07.202923",
  "count": 148,
  "transactions": [
    {
      "id": 7588,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 7589,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 7591,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 7593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 7594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 7597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 7601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 7603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 7606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 7608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 18752,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 18753,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 18755,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 18757,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 18758,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 18761,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 18765,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 18767,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 18770,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 18772,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 32877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 32886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 32890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 32892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 32898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 32908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 32917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 32919,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 32929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 32935,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 50848,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 50859,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 50863,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 50865,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 50871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 50882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 50893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 50896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 50910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 50916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 71357,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 71368,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 71372,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 71374,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 71380,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 71391,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 71402,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 71405,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 71419,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 71425,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 94026,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 94037,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 94042,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 94044,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 94050,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 94062,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 94073,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 94077,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 94091,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 94098,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 118857,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 118868,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 118873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 118875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 118881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 118893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 118904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 118908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 118922,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 118929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 7590,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 7592,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 7595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 7596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 7598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 7599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 7600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 7602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 7604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 7607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 18754,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 18756,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 18759,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 18760,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 18762,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 18763,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 18764,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 18766,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 18768,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 18771,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 32889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 32891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 32905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 32907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 32910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 32913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 32915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 32918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 32921,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 32932,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 50862,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 50864,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 50879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 50881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 50884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 50888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 50890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 50894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 50899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 50913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 71371,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 71373,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 71388,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 71390,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 71393,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 71397,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 71399,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 71403,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 71408,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 71422,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 94040,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 94043,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 94059,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 94061,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 94064,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 94068,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 94070,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 94075,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 94080,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 94095,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 118871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 118874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 118890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 118892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 118895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 118899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 118901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 118906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 118911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 118926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 1215,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 7605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 18769,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 32926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 50905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 71414,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 94086,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 118917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    }
  ]
}